Investor Relations

English Español Português Deutsch

Khiron Life Sciences Re-Files Q2 2020 Interim Financial Statements to Correct Comparative Disclosure and Certain Presentation

View Press Release View All

Nov 12, 2020 • 9:35 AM EST

Khiron Life Sciences Corp. to Present at the virtual Fall Investor Summit on November 16th-18th

Nov 9, 2020 • 11:16 AM EST

Khiron Life Sciences Announces Upsize of Previously Announced Bought Deal Financing to $12.6 Million

Nov 9, 2020 • 7:21 AM EST

Khiron Life Sciences enters into $10 million bought deal financing

View Presentation

Upcoming Events

Nov 30 – Dec 1, 2020

Virtual Presentations Series - 2020 Boston Cannabis Conference

View Event

Nov 30, 2020 • 10:00 am EST

Q3 2020 - Financial Statements Call

View Event Add to Calendar

View All

Q2 2020

Quarter Ended Jun 30, 2020

Earnings Release

PDF HTML

Audio

Earnings Webcast

Financial Statements

PDF

MD&A

PDF

Company Overview

Khiron Life Sciences (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC) is a vertically integrated global medical and CPG cannabis leader with core operations in Latin America and Europe. We currently have distribution throughout various countries in Latin America, along with activity in North America and Europe. The company is licensed in Colombia for the cultivation, production, domestic distribution, and international export of both low and high THC medical cannabis products from Colombia to UK, Peru and Uruguay/Brazil.

View Management Team View Board of Directors

Investor Contact Information

Company

Khiron Life Sciences Corp.
100 King Street West
Suite 1600
Toronto, Ontario M5X 1A9
Canada